Slavinorm after above-knee femoropopliteal bypass: twelve-month comparison
I. A. Suchkov, A. V. Lyasheva, V. O. Povarov, R. E. Kalinin, I. V. Vezenova · 2026 · Angiology and Vascular Surgery. 2026;32(1):28–35. PMID 42289061
Reported findings and study design
60 postoperative patients, 30/30; Slavinorm plus standard care versus standard care.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Ankle–brachial index | Baseline 0.46 / 0.44; twelve months 0.80 / 0.65. | |
| Pain-free walking distance | Baseline 31.5 / 23 m; twelve months 138 / 66 m. | |
| Restenosis as printed | 7 (11.6%) versus 15 (50%). | |
| Bypass thrombosis | 1 (3.3%) versus 4 (13.3%). |
Seven of 30 is 23.3%, so the printed percentage is inconsistent. Reported p<0.001 changes are not verified treatment-by-time effects; no pooled risk estimate calculated.
Source for the extracted data ↗ · Checked 2026-11-06
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Randomization and masking not established; baseline walking differed and both arms underwent surgery.
- Seven cases are printed as 11.6%, inconsistent with 30 participants. The odds-ratio narrative also needs reconciliation.
- No established mortality, amputation or purified-KED benefit.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original publisher abstract
Review depth: Complete abstract checked; full tables unavailable
Source access and review scope
Publisher abstract; follow-up at 1, 3, 6, 9 and 12 months.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Original clinical journal publication
Citation and original source
Original source: I. A. Suchkov, A. V. Lyasheva, V. O. Povarov, R. E. Kalinin, I. V. Vezenova. Slavinorm after above-knee femoropopliteal bypass: twelve-month comparison Angiology and Vascular Surgery. 2026;32(1):28–35. PMID 42289061 2026.
Molekul research summary: https://molekul.io/research/slavinorm-bypass-2026. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry